Autor: |
Darian Andreas, Jeffrey J. Tosoian, Patricia Landis, Sacha Wolf, Stephanie Glavaris, Tamara L. Lotan, Edward M. Schaeffer, Lori J. Sokoll, Ashley E. Ross |
Jazyk: |
angličtina |
Rok vydání: |
2016 |
Předmět: |
|
Zdroj: |
Urology Case Reports, Vol 7, Iss C, Pp 64-66 (2016) |
Druh dokumentu: |
article |
ISSN: |
2214-4420 |
DOI: |
10.1016/j.eucr.2016.04.012 |
Popis: |
The Prostate Health Index (phi) has been FDA approved for decision-making regarding prostate biopsy. Phi has additionally been shown to positively correlate with tumor volume, extraprostatic disease and higher Gleason grade tumors. Here we describe a case in which an elevated phi encouraged biopsy of a gentleman undergoing active surveillance leading to reclassification of his disease as high risk prostate cancer. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|